SI0705828T1 - Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents - Google Patents

Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents

Info

Publication number
SI0705828T1
SI0705828T1 SI9530332T SI9530332T SI0705828T1 SI 0705828 T1 SI0705828 T1 SI 0705828T1 SI 9530332 T SI9530332 T SI 9530332T SI 9530332 T SI9530332 T SI 9530332T SI 0705828 T1 SI0705828 T1 SI 0705828T1
Authority
SI
Slovenia
Prior art keywords
halogen
ome
opt
substd
formula
Prior art date
Application number
SI9530332T
Other languages
English (en)
Slovenian (sl)
Inventor
Uwe Dr. Petersen
Thomas Dr. Schenke
Klaus-Dieter Dr. Bremm
Rainer Dr. Endermann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SI0705828T1 publication Critical patent/SI0705828T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
SI9530332T 1994-10-04 1995-09-21 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents SI0705828T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate
EP95114839A EP0705828B1 (de) 1994-10-04 1995-09-21 Chinolon- und Naphthyridoncarbonsäure-Derivate als antibakterielle Mittel

Publications (1)

Publication Number Publication Date
SI0705828T1 true SI0705828T1 (en) 2000-02-29

Family

ID=6529941

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530332T SI0705828T1 (en) 1994-10-04 1995-09-21 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents

Country Status (40)

Country Link
US (1) US5679689A (cs)
EP (1) EP0705828B1 (cs)
JP (1) JP3794737B2 (cs)
KR (1) KR100371883B1 (cs)
CN (1) CN1063747C (cs)
AT (1) ATE187171T1 (cs)
AU (1) AU697608B2 (cs)
BG (1) BG62965B1 (cs)
CA (1) CA2159547A1 (cs)
CO (1) CO4480031A1 (cs)
CU (1) CU22751A3 (cs)
CZ (1) CZ291616B6 (cs)
DE (2) DE4435479A1 (cs)
DK (1) DK0705828T3 (cs)
DZ (1) DZ1933A1 (cs)
EE (1) EE03443B1 (cs)
ES (1) ES2140599T3 (cs)
FI (1) FI954680A7 (cs)
GR (1) GR3032659T3 (cs)
HR (1) HRP950469B1 (cs)
HU (1) HUT73429A (cs)
IL (2) IL130921A (cs)
MA (1) MA23682A1 (cs)
MY (1) MY113196A (cs)
NO (1) NO307514B1 (cs)
NZ (1) NZ280129A (cs)
PE (1) PE29698A1 (cs)
PL (1) PL182812B1 (cs)
PT (1) PT705828E (cs)
RO (1) RO115261B1 (cs)
RU (1) RU2145604C1 (cs)
SG (1) SG38880A1 (cs)
SI (1) SI0705828T1 (cs)
SK (1) SK280877B6 (cs)
SV (1) SV1995000063A (cs)
TN (1) TNSN95099A1 (cs)
TW (1) TW364908B (cs)
UA (1) UA42797C2 (cs)
YU (1) YU63595A (cs)
ZA (1) ZA958296B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
CA2518443A1 (en) * 2003-03-12 2004-09-30 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
AU2007339692B2 (en) 2007-01-05 2012-01-19 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
PH12022551260A1 (en) * 2019-11-28 2024-06-03 Bayer Ag Substituted aminoquinolones as dgkalpha inhibitors for immune activation
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
EP0812838B1 (en) * 1994-02-04 2002-05-02 Dainippon Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
ATE187171T1 (de) 1999-12-15
CZ256895A3 (en) 1996-04-17
UA42797C2 (uk) 2001-11-15
IL115492A (en) 1999-12-22
CN1126211A (zh) 1996-07-10
AU697608B2 (en) 1998-10-15
SK280877B6 (sk) 2000-08-14
DE4435479A1 (de) 1996-04-11
JP3794737B2 (ja) 2006-07-12
BG62965B1 (bg) 2000-12-29
MY113196A (en) 2001-12-31
ES2140599T3 (es) 2000-03-01
SG38880A1 (en) 1997-04-17
FI954680A0 (fi) 1995-10-02
DZ1933A1 (fr) 2002-02-17
TNSN95099A1 (fr) 1996-02-06
AU3291995A (en) 1996-04-18
PL182812B1 (pl) 2002-03-29
NO307514B1 (no) 2000-04-17
EP0705828A1 (de) 1996-04-10
DE59507324D1 (de) 2000-01-05
US5679689A (en) 1997-10-21
HRP950469B1 (en) 2000-12-31
FI954680L (fi) 1996-04-05
SV1995000063A (es) 1996-07-24
CZ291616B6 (cs) 2003-04-16
HRP950469A2 (en) 1997-08-31
RO115261B1 (ro) 1999-12-30
CU22751A3 (es) 2002-02-28
YU63595A (sh) 1998-08-14
PT705828E (pt) 2000-04-28
FI954680A7 (fi) 1996-04-05
NO953931L (no) 1996-04-09
RU2145604C1 (ru) 2000-02-20
KR100371883B1 (ko) 2003-03-29
KR960014118A (ko) 1996-05-22
ZA958296B (en) 1996-05-07
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
TW364908B (en) 1999-07-21
SK123895A3 (en) 1996-06-05
CA2159547A1 (en) 1996-04-05
EE03443B1 (et) 2001-06-15
BG100041A (bg) 1996-05-31
HU9502888D0 (en) 1995-11-28
PL310747A1 (en) 1996-04-15
IL130921A (en) 2001-10-31
EE9500069A (et) 1996-04-15
CN1063747C (zh) 2001-03-28
HUT73429A (en) 1996-07-29
DK0705828T3 (da) 2000-05-15
JPH08225567A (ja) 1996-09-03
NO953931D0 (no) 1995-10-03
CO4480031A1 (es) 1997-07-09
NZ280129A (en) 1996-06-25
MA23682A1 (fr) 1996-07-01
EP0705828B1 (de) 1999-12-01
PE29698A1 (es) 1998-08-27

Similar Documents

Publication Publication Date Title
PH24048A (en) Substituted bridged-diazabicycloalkyl quinolone carboxylic acids,pharmaceutical compositions containing them and anti-bacterial use thereof
KR930016421A (ko) 퀴놀론- 및 나프티리돈-카르복실산 유도체
GR3032659T3 (en) Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents
FI104077B (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatso£1,2-a|(pyrrolo-, tieno- tai furano)£3,2-d|atsepiinijohdannaisten valmistamiseksi ja välituote
KR100258395B1 (en) Benzo(b)thiophen-3-yl-piperazines, a process for their preparation and pharmaceutical composition containing them
AU2025695A (en) 1,9-bridged thiazolo(3,2-a)quinoline derivatives
GR3018746T3 (en) 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation
DK0721948T3 (da) Quinolon- og naphthyridoncarboxylsyrederivater somantibakterielle midler

Legal Events

Date Code Title Description
KO00 Lapse of patent

Effective date: 20041201